Bahce, Idris <br/><br/>
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jan 2013 
 - 183-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-0289  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Base Sequence<br/>Carbon Radioisotopes--chemistry<br/>Carcinoma, Non-Small-Cell Lung--diagnostic imaging<br/>ErbB Receptors--genetics<br/>Erlotinib Hydrochloride<br/>Exons<br/>Female<br/>Humans<br/>Lung Neoplasms--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Multimodal Imaging--methods<br/>Mutation<br/>Neoplasm Staging<br/>Positron-Emission Tomography<br/>Quinazolines--chemistry<br/>Tomography, X-Ray Computed